Kim BJ - Search Results

1

Jang YJ, Kim H, Ryu SY, Kim MH, Kim BJ, Jung HJ, Kang J, Yang SH, Na II, Lee HR, Kang HJ. Jang YJ, et al. Among authors: kim h, kim bj, kim mh. Transl Cancer Res. 2024 Nov 30;13(11):6018-6027. doi: 10.21037/tcr-24-1131. Epub 2024 Nov 12. Transl Cancer Res. 2024. PMID: 39697762 Free PMC article.

2

Risk of metastatic ovarian involvement in nongynecologic malignancies.

Kim K, Cho SY, Park SI, Kang HJ, Kim BJ, Kim MH, Choi SC, Ryu SY, Lee ED. Kim K, et al. Among authors: kim bj, kim mh. Int J Gynecol Cancer. 2012 Jan;22(1):3-8. doi: 10.1097/IGC.0b013e3182332cd1. Int J Gynecol Cancer. 2012. PMID: 22193640

3

Characteristics of thyroid incidentalomas detected by pre-treatment [F]FDG PET or PET/CT in patients with cervical cancer.

Lee WM, Kim BJ, Kim MH, Choi SC, Ryu SY, Lim I, Kim K. Lee WM, et al. Among authors: kim bj, kim mh, kim k. J Gynecol Oncol. 2012 Jan;23(1):43-7. doi: 10.3802/jgo.2012.23.1.43. Epub 2012 Jan 9. J Gynecol Oncol. 2012. PMID: 22355466 Free PMC article.

4

Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.

Kim TH, Kim MH, Kim BJ, Park SI, Ryu SY, Cho CK. Kim TH, et al. Among authors: kim bj, kim mh. Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1124-1131. doi: 10.1016/j.ijrobp.2017.03.029. Epub 2017 Mar 27. Int J Radiat Oncol Biol Phys. 2017. PMID: 28721896

5

Prognostic significance of pretreatment lymphocyte percentage and age at diagnosis in patients with locally advanced cervical cancer treated with definite radiotherapy.

Jeong MH, Kim H, Kim TH, Kim MH, Kim BJ, Ryu SY. Jeong MH, et al. Among authors: kim h, kim th, kim bj, kim mh. Obstet Gynecol Sci. 2019 Jan;62(1):35-45. doi: 10.5468/ogs.2019.62.1.35. Epub 2018 Dec 3. Obstet Gynecol Sci. 2019. PMID: 30671392 Free PMC article.

6

Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors?

Ryu SY, Park SI, Nam BH, Cho CK, Kim K, Kim BJ, Kim MH, Choi SC, Lee ED, Lee KH. Ryu SY, et al. Among authors: kim bj, kim mh, kim k. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):794-9. doi: 10.1016/j.ijrobp.2009.11.019. Epub 2010 Apr 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 20421158

7

Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease.

Ryu SY, Kim K, Kim Y, Park SI, Kim BJ, Kim MH, Choi SC, Lee ED, Lee KH, Kim BI. Ryu SY, et al. Among authors: kim bi, kim bj, kim mh, kim y, kim k. J Korean Med Sci. 2010 Jul;25(7):1029-33. doi: 10.3346/jkms.2010.25.7.1029. Epub 2010 Jun 17. J Korean Med Sci. 2010. PMID: 20592894 Free PMC article.

8

The type of metastasis is a prognostic factor in disseminated cervical cancer.

Kim K, Cho SY, Kim BJ, Kim MH, Choi SC, Ryu SY. Kim K, et al. Among authors: kim bj, kim mh. J Gynecol Oncol. 2010 Sep;21(3):186-90. doi: 10.3802/jgo.2010.21.3.186. Epub 2010 Sep 28. J Gynecol Oncol. 2010. PMID: 20922142 Free PMC article.

9

Discharge criteria should be validated in patients who undergo ambulatory gynecologic surgery.

Kim K, Kim BJ, Kim MH, Choi SC, Ryu SY. Kim K, et al. Among authors: kim bj, kim mh. J Gynecol Oncol. 2011 Jun 30;22(2):140-1. doi: 10.3802/jgo.2011.22.2.140. J Gynecol Oncol. 2011. PMID: 21860742 Free PMC article. No abstract available.

10

Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer.

Lee WM, Park SI, Kim BJ, Kim MH, Choi SC, Lee ED, Ryu SY. Lee WM, et al. Among authors: kim bj, kim mh. Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):219-23. doi: 10.1016/j.ejogrb.2011.12.029. Epub 2012 Feb 10. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22326616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,155 results

Search Page

Filters